Welcome Our New Entrepreneur in Residence: Dr. Kuldeep Neote

CvilleBioHub is proud to welcome Dr. Kuldeep Neote as our newest Entrepreneur in Residence (EIR).

Kuldeep is a veteran biopharma executive with more than 30 years of experience in drug discovery, licensing, and new venture creation. He has held senior roles at Pfizer, Eli Lilly, and Johnson & Johnson, including Vice President, External Innovation at Eli Lilly, where he led the company’s New Venture initiative and helped enable its acquisition of Prevail Therapeutics, and Senior Director, New Ventures at J&J Innovation, where he established multiple collaborations and served as interim Head of JLABS@Canada.

Kuldeep holds a Ph.D. in Medical Genetics from the University of Toronto and a B.Sc. in Molecular & Cellular Biology from the University of Calgary.

“I’m excited to join CvilleBioHub as an Entrepreneur in Residence and to work alongside founders who are translating scientific breakthroughs into real therapies,” said Neote. “Drawing on decades of experience in drug discovery, licensing, and new venture creation, I look forward to helping our founders build companies that can translate cutting edge discoveries and technologies, develop a commercialization strategy, attract investment and ultimately reach patients.”

“Kuldeep brings a rare combination of deep drug discovery expertise and dealmaking experience,” said Nikki Hastings. “He’s helped build new ventures inside some of the world’s largest pharmaceutical companies and has a track record of translating science into successful biotech spinouts. We’re thrilled to welcome him to CvilleBioHub.”